EUVIMEDEUVIMED entdecken
Crossref

Amuc_1434 From Akkermansia muciniphila Enhances CD8 + T Cell‐Mediated Anti‐Tumor Immunity by Suppressing PD ‐ L1 in Colorectal Cancer

Jiahao Zhu, Shaolei Qin, Ruike Gu, Shengjun Ji, Gang Wu, Ke Gu iD

The FASEB Journal · 30.04.2025 · 39 (8)

DOI: 10.1096/fj.202403295rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 15.04.2025. Verfasst von Jiahao Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy and Oncology, The Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, People's Republic of China. Hauptthemen laut MEDLINE: B7-H1 Antigen, CD8-Positive T-Lymphocytes, Colorectal Neoplasms, Akkermansia. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Wuxi Taihu Lake Talent Plan, Support for Leading Talents in Medical and Health Profession and Project of Wuxi Institute of Translational Medicine, The Scientific Research Project of Wuxi Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) shows a limited response to programmed death‐ligand 1 (PD‐L1) immunotherapies. Akkermansia muciniphila (AKK) may enhance tumor immunity. This study examines how its Outer Membrane Vesicles (OMVs) and Amuc_1434 influence PD‐L1 expression and CD8+ T cell activity in CRC. OMVs were isolated and their characteristics were examined through transmission electron microscopy and Western blotting. PD‐L1 expression was quantified via Western blot, while CD8+ T cell proliferation was measured using flow cytometry. Cytokine production (interferon‐gamma (IFN‐γ) and interleukin‐2 (IL‐2)) was evaluated using ELISA. A CRC mouse model was employed to examine its impact on tumor growth and immune cell infiltration. In CRC cells, treatment with AKK‐derived OMVs (AKK‐OMVs) significantly downregulated PD‐L1 expression ( p < 0.05) and markedly increased CD8+ T cell proliferation and the levels of IFN‐γ and IL‐2 ( p < 0.01). Amuc_1434 was identified as the key protein mediating these effects. In vivo, AKK‐OMVs treatment substantially reduced tumor volume ( p < 0.01) and significantly enhanced CD8+ T cell infiltration into the tumor microenvironment ( p < 0.01). Additionally, AKK‐OMVs‐treated mice showed increased expression of immune activation markers within the tumor tissue, further indicating enhanced antitumor immunity. This study reveals that AKK‐OMVs, particularly those containing Amuc_1434, can modulate PD‐L1 expression and potentiate CD8+ T cell‐mediated antitumor immunity in CRC. These findings suggest a novel approach to overcoming resistance to immune checkpoint inhibitors in CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenCD8-Positive T-LymphocytesColorectal NeoplasmsAkkermansiaAnimalsMiceHumansFemaleCell Line, TumorCell ProliferationMice, Inbred C57BL

Stichwörter der Autor:innen

Akkermansia muciniphilaAmuc_1434PD‐L1colorectal cancerouter membrane vesicles

Substanzen

B7-H1 AntigenCD274 protein, humanCd274 protein, mouse

Autor:innen und Institutionen

  • Department of Radiotherapy and Oncology, The Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, People's Republic of China.
  • Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, People's Republic of China.
  • Department of Rehabilitation Medical, Suzhou Rehabilitation Hospital (Suzhou Municipal Hospital Rehabilitation Medical Center), Suzhou, Jiangsu, People's Republic of China.
  • Department of Radiotherapy and Oncology, The Affiliated Suzhou Hospital of Nanjing Medical University, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, People's Republic of China.

ORCID-Profile: Ke Gu

Förderung

  • Wuxi Taihu Lake Talent Plan, Support for Leading Talents in Medical and Health Profession and Project of Wuxi Institute of Translational Medicine
  • The Scientific Research Project of Wuxi Municipal Health Commission

Zitieren

APA

Zhu, J., Qin, S., Gu, R., Ji, S., Wu, G., & Gu, K. (2025). Amuc_1434 From Akkermansia muciniphila Enhances CD8 + T Cell‐Mediated Anti‐Tumor Immunity by Suppressing PD ‐ L1 in Colorectal Cancer. The FASEB Journal, 39(8). https://doi.org/10.1096/fj.202403295rr

Vancouver

Zhu J, Qin S, Gu R, Ji S, Wu G, Gu K. Amuc_1434 From Akkermansia muciniphila Enhances CD8 + T Cell‐Mediated Anti‐Tumor Immunity by Suppressing PD ‐ L1 in Colorectal Cancer. The FASEB Journal. 2025;39(8). doi:10.1096/fj.202403295rr

BibTeX
@article{Zhu2025,
  author = {Zhu, Jiahao and Qin, Shaolei and Gu, Ruike and Ji, Shengjun and Wu, Gang and Gu, Ke},
  title = {Amuc_1434 From Akkermansia muciniphila Enhances CD8 + T Cell‐Mediated Anti‐Tumor Immunity by Suppressing PD ‐ L1 in Colorectal Cancer},
  journal = {The FASEB Journal},
  year = {2025},
  volume = {39},
  number = {8},
  doi = {10.1096/fj.202403295rr}
}
Kostenlos starten →